Description
Cifran OD (Ciprofloxacin) Tablets with Prolonged Release 500 mg. №5
Composition:
Each tablet contains 500 mg of ciprofloxacin.
Mechanism of Action:
Ciprofloxacin, the active ingredient in Cifran OD, inhibits the bacterial DNA gyrase enzyme, preventing DNA supercoiling and replication.
Pharmacological Properties:
Ciprofloxacin disrupts bacterial DNA replication by inhibiting DNA gyrase, leading to the inhibition of bacterial growth and reproduction.
Indications for Use:
Cifran OD tablets are indicated for the treatment of various bacterial infections, including urinary tract infections, respiratory tract infections, skin and soft tissue infections, and bone and joint infections.
Contraindications:
Avoid Cifran OD if allergic to ciprofloxacin or other fluoroquinolones. Contraindicated in children, pregnant women, and breastfeeding mothers.
Side Effects:
Possible side effects include gastrointestinal disturbances, skin reactions, and central nervous system effects. Contact your healthcare provider if you experience severe or persistent side effects.
Usage Instructions:
The typical dosage is one tablet daily with a full glass of water, with or without food. Follow healthcare provider instructions carefully and do not exceed the recommended dosage or treatment duration.
Benefits Compared to Analogues:
Cifran OD offers the advantage of once-daily dosing due to its prolonged-release formulation, enhancing patient compliance and convenience compared to other antibiotics.
Suitable Patient Groups:
Cifran OD is suitable for adult patients. Use in children, pregnant women, and breastfeeding mothers is contraindicated.
Storage and Shelf Life:
Store Cifran OD in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use after the specified date.
Packaging Description:
Cifran OD tablets are packaged in blister packs of 5 tablets each, ensuring protection and ease of use.
Clinical Evidence and Proven Effectiveness:
Clinical studies have demonstrated the efficacy of ciprofloxacin in treating various infections. The prolonged-release formulation of Cifran OD has shown comparable effectiveness to other antibiotics in its class, as evidenced by studies such as the one by Peterson et al. in the New England Journal of Medicine.
